PolyPid Ltd.
NASDAQ:PYPDBiotechnology
+$0.39 today
- Market cap
- $133.25M
- Beta
- 1.43
- P/E (TTM)
- -2.7
- EPS (TTM)
- -$1.53
Volume 0.30M
Average 0.09M
PYPD Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
PolyPid Ltd.NASDAQ: PYPD
Net Change in Cash · Q4 FY2025 · quarter ended Dec 2025
Net change in cash of -$3.26M in Q4 FY2025
Q4 FY2025 net change in cash was -$3.26M. Trailing-twelve-month net change in cash was -$9.21M. Over 3 fiscal years it compounded at +99.9% a year.
Context
- Net change in cash increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly net change in cash holds near -$3.26M or moves back toward the trailing-twelve-month quarterly average of -$2.3M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- (9.21M) USD
- Year-over-year change
- -190.3%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (9.21M) | -190.3% |
| FY2024 | 2024-12-31 | 10.2M | +395.3% |
| FY2023 | 2023-12-31 | (3.45M) | -199.6% |
| FY2022 | 2022-12-31 | (1.15M) | -120.9% |
| FY2021 | 2021-12-31 | 5.51M | — |
Net Change in Cash vs competitors
How PYPD compares with its peers on the latest reported figures
- PYPD's LTM Dec 2025 net change in cash of $9.21M is the 4th largest of the 7 companies compared; the peer median is $1.37M.
- Over three fiscal years its annual growth of +99.9% compares with a peer median of -40.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $5.06B | +18900.6% | — | — | |
| LTM Mar 2026 | $23.55M | +808.6% | — | — | |
| LTM Jun 2026 | $23.45M | -10.2% | — | 66.8% | |
| LTM Dec 2025 | $9.21M | — | +99.9% | — | |
| LTM Mar 2026 | $8.02M | -142.0% | — | — | |
| LTM Mar 2026 | $7.58M | +151.5% | -40.0% | — | |
| LTM Dec 2025 | $5.27M | +547.5% | — | 19.9% | |
| Peer median (excluding PYPD) | $1.37M | +349.5% | -40.0% | 43.3% | |
Competitors are the stored peer set for PYPD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (42.6M) | (39.56M) | (23.87M) | (29.02M) | (34.17M) |
| Depreciation & Amortization | 1.12M | 1.72M | 1.82M | 1.62M | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 4.35M | (1.08M) | (110K) | 1.92M | 0 |
| Accounts Receivables | 123K | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.22M | (3.1M) | (369K) | 1.64M | 0 |
| Other Working Capital | 2M | 2.02M | 259K | 279K | 0 |
| Other Non-Cash Items | 4.75M | 4.6M | 4.92M | 3.52M | 34.17M |
| Operating Cash Flow | (32.39M) | (34.32M) | (17.24M) | (21.96M) | 0 |
| Capital Expenditures | (2.99M) | (1.77M) | (196K) | (76K) | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (18.6M) | (21.35M) | 0 |
| Sales of Investments | 39.89M | 18.34M | 22.6M | 21.1M | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 36.9M | 16.58M | 3.8M | (330K) | 0 |
| Debt Repayment | 0 | 11.31M | (2.62M) | (3.32M) | 0 |
| Common Stock Issued | 1.03M | 5.12M | 12.72M | 35.86M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | (125K) | (125K) | 0 |
| Financing Cash Flow | 1.03M | 16.43M | 9.98M | 32.42M | 0 |
| Effect of Forex Changes | (41K) | 161K | 2K | 77K | (9.21M) |
| Net Change in Cash | 5.51M | (1.15M) | (3.45M) | 10.2M | (9.21M) |
| Free Cash Flow | (35.38M) | (36.08M) | (17.43M) | (22.04M) | 0 |
PolyPid Ltd.
NASDAQ:PYPD
Intrinsic Alpha fair value
Locked
Current Price
$6.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.